USPTO serial 79392161
ABSELION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 13, 2025
- Examiner
- ROTH, BENJAMIN H.
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ABSELION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel J. Smola
Daniel J. Smola Hahn Loeser & Parks LLP200 Public Square, Suite 2800Cleveland, OH 44114United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for protein analysis for scientific, research and manufacturing use; chemical reagents, other than for medical or veterinary purposes, for use in genetic and DNA research; chemical reagents for non-medical and non-veterinary purposes, namely, for analysing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates and functional properties of biomolecules, namely, chemical compounds, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, virus, bacteria, antibodies and antibody fragments; reagent kits comprised of biochemical reagents, other than for medical or veterinary purposes, for use in protein analysis, detection, identification, characterisation, and separation comprised of assays and reagents for use in genetic research, biomarker research, and antibody research; reagent kits comprised of biochemical reagents, other than for medical or veterinary purposes, for use in biomolecular analysis, detection, identification, characterisation, and separation comprised of assays and reagents for use in genetic research, biomarker research, and antibody research; reagent kits comprised of biochemical reagents, other than for medical or veterinary purposes, for use in genetic and DNA analysis, detection, identification, characterisation, and separation comprised of assays and reagents for use in genetic research, biomarker research, and antibody research | ACTIVE | — |
| 009 | Laboratory instruments, namely, devices for molecular analysis of proteins; laboratory instruments for protein analysis including chemical and biochemical reactions; laboratory apparatus and instruments for biomolecular analysis; laboratory apparatus and instruments for the analysis of proteins; laboratory apparatus and instruments for the analysis of biomolecules and biological molecules; laboratory apparatus and instruments for genetic and DNA analysis; laboratory apparatus and instruments for the automation of biomolecular analysis, namely, an instrument comprising computer hardware and downloadable computer software for operating biomolecular analysis equipment for laboratory purposes; laboratory apparatus and instruments for the automation of protein analysis, namely, an instrument comprising computer hardware and downloadable computer software for operating protein analysis equipment for laboratory purposes; laboratory apparatus and instruments for the automation of biomolecule and biological molecule analysis, namely, an instrument comprising computer hardware and downloadable computer software for operating biomolecule and biological molecule analysis equipment for laboratory purposes; laboratory apparatus and instruments for the automation of genetic and DNA analysis, namely, an instrument comprising computer hardware and downloadable computer software for operating DNA analysis equipment for laboratory purposes; laboratory apparatus and instruments for drug development and drug discovery in the field of biotechnology, namely, an instrument comprising computer hardware and downloadable computer software for visualizing pharmaceutical drug properties and drug concentrations; devices for analysing protein used as laboratory apparatus, namely, laboratory apparatus and computer systems comprised of computer hardware and recorded computer software for use in analysing proteins; devices for analysing biomolecules and biological molecules used as laboratory apparatus, namely, laboratory apparatus and computer systems comprised of computer hardware and recorded computer software for analysing biomolecules and biological molecules; devices for genetic and DNA analysis used as laboratory apparatus, namely, laboratory apparatus and computer systems comprised of computer hardware and recorded computer software for genetic and DNA analysis; downloadable computer software for protein analysis; downloadable computer software for biomolecule and biological molecule analysis; downloadable computer software for genetic and DNA analysis; protein analysis equipment comprising computer hardware, recorded software, and computer display screens for protein detection, and analysis; biomolecule and biological molecule analysis equipment comprising computer hardware, software, and display screens for protein detection, and analysis; genetic and DNA analysis equipment comprising computer hardware, recorded software, and computer display screens for protein detection, and analysis; protein analysis equipment comprising sensors for protein detection, and analysis; biomolecule and biological molecule analysis equipment comprising sensors for protein detection, and analysis; genetic and DNA analysis equipment comprising sensors for protein detection, and analysis; instruments containing electrical, computer and chemical hardware, namely, data processing apparatus and sensor chips for scientific use for the analysis of proteins; instruments containing electrical, computer and chemical hardware, namely, data processing apparatus and sensor chips for scientific use for the analysis of biomolecules and biological molecules; instruments containing electrical, computer and chemical hardware, namely, data processing apparatus and sensor chips for scientific use for genetic and DNA analysis; biosensors for analysing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, proteins; biosensors for use in biomolecular measurement, quantification, kinetics, protein analysis, clinical research applications, drug development and nucleic acid interaction, antibody and antibody fragment characterisation, protein- protein interactions, protein-peptide interactions, protein-DNA/RNA interactions, protein-lipid interactions, virus and vaccine research, protein-small molecule interactions, cell-based assays being cellular secretions in response to a protein presence; instruments containing electrical, computer and chemical hardware , namely, data processing apparatus and sensor chips for scientific use for the analysis of DNA, RNA, and cells; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and laboratory equipment for making molecular arrays, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein and structural and replacement parts and fittings therefor; biosensors for analysing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, chemical compounds, sugars, peptides, oligonucleotides, DNA, RNA, cells, virus, aptamers, bacteria, antibodies and antibody fragments; all of the aforegoing goods not being for medical use | ACTIVE | — |
| 042 | biotechnology research and development services; research and development in the field of biomolecular analysis; research and development in the field of protein analysis; research and development in the field of genetic and DNA analysis; pharmaceutical drug development and drug discovery services; pharmaceutical drug development and drug discovery services in the field of biomolecular sciences; scientific research consultancy and advisory services in the field of biomolecular analysis; scientific research consultancy and advisory services in the field of protein analysis; consultancy and advisory services relating to research and development in the field of therapeutics; consultancy and advisory services relating to research and development in the field of protein analysis; consultancy and advisory services relating to research and development in the field of biomolecule and biological molecule analysis; consultancy and advisory services relating to research and development in the field of genetic and DNA analysis; design and development of laboratory apparatus and instruments; design and development of laboratory apparatus and instruments and computer systems for use in the analysis of protein; design and development of laboratory apparatus and instruments and computer systems for use in the analysis of biomolecules and biological molecules; design and development of laboratory apparatus and instruments and computer systems for use in genetic and DNA analysis; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analysing proteins and other biological molecules; protein screening for scientific research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HexagonFab Ltd.
- Other trademarks owned by HexagonFab Ltd.
- Other trademarks owned by HexagonFab Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ABSELION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 18, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 7, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 7, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 27, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 27, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 13, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 13, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 13, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 25, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 25, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 19, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 4, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 18, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 18, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 18, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 18, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 5, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 5, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 15, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 12, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 29, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 28, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |